Jennifer Gunter & Eric Topol - Discuss Womenâs Health and Recent Changes by FDA for MHT
I mean, if you look at the wise woman hypothesis, which is the idea that women in menopause basically helped drive evolution because they were there to care for, provide assistance to their own children and their grandchildren.
Jennifer Gunter & Eric Topol - Discuss Womenâs Health and Recent Changes by FDA for MHT
So yeah, I think when people talk about ovarian failure, to me, that means that they have a very poor understanding of kind of the biology of ovulation and the biology of a menstrual cycle versus estrus.
Jennifer Gunter & Eric Topol - Discuss Womenâs Health and Recent Changes by FDA for MHT
So, for example, when women sort of approach their late 30s, early 40s, their incidence of two conditions, adenomyosis and fibroids, starts to increase dramatically.
Jennifer Gunter & Eric Topol - Discuss Womenâs Health and Recent Changes by FDA for MHT
And so what is going to happen to those uteruses if they're keeping getting exposed to sort of estrogen in their 50s and 60s and 70s, like from ovulation, not from menopausal hormone therapy, which is a lower amount, right?
Jennifer Gunter & Eric Topol - Discuss Womenâs Health and Recent Changes by FDA for MHT
you know, I think that we have to be super careful about the assumptions that we make and about the cherry picking and this idea that longevity is going to be expanded by expanding ovulation.